Evidence of demyelination in mild cognitive impairment and dementia using a direct and specific magnetic resonance imaging measure of myelin content

[1]  Ninon Burgos,et al.  New advances in the Clinica software platform for clinical neuroimaging studies , 2019 .

[2]  C. Lebel,et al.  A review of diffusion MRI of typical white matter development from early childhood to young adulthood , 2019, NMR in biomedicine.

[3]  M. Mintun,et al.  Trial of Solanezumab for Mild Dementia Due to Alzheimer's Disease , 2018, The New England journal of medicine.

[4]  M. Murphy.  Amyloid-Beta Solubility in the Treatment of Alzheimer's Disease. , 2018, The New England journal of medicine.

[5]  Richard G. Spencer,et al.  Rapid simultaneous high-resolution mapping of myelin water fraction and relaxation times in human brain using BMC-mcDESPOT , 2017, NeuroImage.

[6]  Sterling C. Johnson,et al.  Association of Amyloid Pathology With Myelin Alteration in Preclinical Alzheimer Disease , 2017, JAMA neurology.

[7]  Jeffrey A. Stanley,et al.  Adult age differences in subcortical myelin content are consistent with protracted myelination and unrelated to diffusion tensor imaging indices , 2016, NeuroImage.

[8]  A. MacKay,et al.  Magnetic Resonance of Myelin Water: An in vivo Marker for Myelin , 2016, Brain plasticity.

[9]  Steen Moeller,et al.  The Human Connectome Project's neuroimaging approach , 2016, Nature Neuroscience.

[10]  Richard Kijowski,et al.  Analysis of mcDESPOT‐ and CPMG‐derived parameter estimates for two‐component nonexchanging systems , 2016, Magnetic resonance in medicine.

[11]  J. Hardy,et al.  The amyloid hypothesis of Alzheimer's disease at 25 years , 2016, EMBO molecular medicine.

[12]  Richard G. Spencer,et al.  Improved determination of the myelin water fraction in human brain using magnetic resonance imaging through Bayesian analysis of mcDESPOT , 2016, NeuroImage.

[13]  M. Owen,et al.  Alzheimer's disease: The amyloid hypothesis on trial , 2016, British Journal of Psychiatry.

[14]  David T. Jones,et al.  Cascading network failure across the Alzheimer’s disease spectrum , 2015, Brain : a journal of neurology.

[15]  Mustapha Bouhrara,et al.  Incorporation of nonzero echo times in the SPGR and bSSFP signal models used in mcDESPOT , 2015, Magnetic resonance in medicine.

[16]  Susan A. Gauthier,et al.  Measuring longitudinal myelin water fraction in new multiple sclerosis lesions , 2015, NeuroImage: Clinical.

[17]  Jerry L Prince,et al.  Changes in Aβ biomarkers and associations with APOE genotype in 2 longitudinal cohorts , 2015, Neurobiology of Aging.

[18]  A. MacKay,et al.  Advanced imaging in lesion and normal-appearing white matter over 2 years in MS patients treated with alemtuzumab (S29.009) , 2015 .

[19]  G. B. Pike,et al.  MRI‐based myelin water imaging: A technical review , 2015, Magnetic resonance in medicine.

[20]  Jing Zhang,et al.  Comparison of myelin water fraction from multiecho T2 decay curve and steady‐state methods , 2015, Magnetic resonance in medicine.

[21]  Keith A. Johnson,et al.  The Evolution of Preclinical Alzheimer’s Disease: Implications for Prevention Trials , 2014, Neuron.

[22]  Gary F. Egan,et al.  A review of β-amyloid neuroimaging in Alzheimer's disease , 2014, Front. Neurosci..

[23]  B. Vissel,et al.  Inconsistencies and Controversies Surrounding the Amyloid Hypothesis of Alzheimer's Disease , 2014, Acta neuropathologica communications.

[24]  G. Bloom.  Amyloid-β and tau: the trigger and bullet in Alzheimer disease pathogenesis. , 2014, JAMA neurology.

[25]  John Hardy,et al.  Antiamyloid therapy for Alzheimer's disease--are we on the right road? , 2014, The New England journal of medicine.

[26]  E. Siemers,et al.  Phase 3 trials of solanezumab for mild-to-moderate Alzheimer's disease. , 2014, The New England journal of medicine.

[27]  Richard S. J. Frackowiak,et al.  Demyelination in Mild Cognitive Impairment Suggests Progression Path to Alzheimer’s Disease , 2013, PloS one.

[28]  Demetris K. Roumis,et al.  Synaptic Plasticity Defect Following Visual Deprivation in Alzheimer's Disease Model Transgenic Mice , 2012, The Journal of Neuroscience.

[29]  Charles D. Smith,et al.  Multimodal imaging evidence for axonal and myelin deterioration in amnestic mild cognitive impairment. , 2012, Journal of Alzheimer's disease : JAD.

[30]  B. Hyman,et al.  Neuropathological alterations in Alzheimer disease. , 2011, Cold Spring Harbor perspectives in medicine.

[31]  G. Bartzokis.  Alzheimer's disease as homeostatic responses to age-related myelin breakdown , 2011, Neurobiology of Aging.

[32]  S. Deoni,et al.  Correction of main and transmit magnetic field (B0 and B1) inhomogeneity effects in multicomponent‐driven equilibrium single‐pulse observation of T1 and T2 , 2011, Magnetic resonance in medicine.

[33]  Bill Seeley,et al.  Neurodegenerative diseases target large-scale human brain networks , 2010, Alzheimer's & Dementia.

[34]  G. B. Pike,et al.  Reproducibility of in vivo magnetic resonance imaging–based measurement of myelin water , 2010, Journal of magnetic resonance imaging : JMRI.

[35]  Sean C L Deoni,et al.  Quantitative Relaxometry of the Brain , 2010, Topics in magnetic resonance imaging : TMRI.

[36]  Klaus-Armin Nave,et al.  Myelination and the trophic support of long axons , 2010, Nature Reviews Neuroscience.

[37]  J. Trojanowski,et al.  Early marker for Alzheimer's disease: Hippocampus T1rho (T1ρ) estimation , 2009, Journal of magnetic resonance imaging : JMRI.

[38]  Joseph Ross Mitchell,et al.  Multiexponential T2 and magnetization transfer MRI of demyelination and remyelination in murine spinal cord , 2009, NeuroImage.

[39]  B. Todorich,et al.  Oligodendrocytes and myelination: The role of iron , 2009, Glia.

[40]  B. Mädler,et al.  MR relaxation in multiple sclerosis. , 2009, Neuroimaging clinics of North America.

[41]  Derek K. Jones,et al.  Gleaning multicomponent T1 and T2 information from steady‐state imaging data , 2008, Magnetic resonance in medicine.

[42]  Seth Love,et al.  Long-term effects of Aβ42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial , 2008, The Lancet.

[43]  Piotr Kozlowski,et al.  Myelin water imaging of multiple sclerosis at 7 T: Correlations with histopathology , 2008, NeuroImage.

[44]  John D. Carew,et al.  Investigating the Medial Temporal Lobe in Alzheimer’s Disease and Mild Cognitive Impairment, with Turboprop Diffusion Tensor Imaging, MRI-volumetry, and T2-relaxometry , 2007, Brain Imaging and Behavior.

[45]  Jim Mintz,et al.  Human brain myelination and amyloid beta deposition in Alzheimer’s disease , 2007, Alzheimer's & Dementia.

[46]  C. Jack,et al.  Alzheimer's Disease Neuroimaging Initiative , 2008 .

[47]  Benjamin J. Shannon,et al.  Molecular, Structural, and Functional Characterization of Alzheimer's Disease: Evidence for a Relationship between Default Activity, Amyloid, and Memory , 2005, The Journal of Neuroscience.

[48]  Rajiv Midha,et al.  Histological and magnetic resonance analysis of sciatic nerves in the tellurium model of neuropathy , 2005, Journal of the peripheral nervous system : JPNS.

[49]  Jim Mintz,et al.  Quantifying age-related myelin breakdown with MRI: novel therapeutic targets for preventing cognitive decline and Alzheimer's disease. , 2005, Journal of Alzheimer's disease : JAD.

[50]  C. Laule,et al.  Water content and myelin water fraction in multiple sclerosis , 2004, Journal of Neurology.

[51]  G. Bartzokis.  Age-related myelin breakdown: a developmental model of cognitive decline and Alzheimer’s disease , 2004, Neurobiology of Aging.

[52]  J. Hardy,et al.  The Amyloid Hypothesis of Alzheimer ’ s Disease : Progress and Problems on the Road to Therapeutics , 2009 .

[53]  W. M. van der Flier,et al.  Magnetization transfer imaging in normal aging, mild cognitive impairment, and Alzheimer's disease , 2002, Annals of neurology.

[54]  John G. Sled,et al.  Magnetization Transfer Ratio in Mild Cognitive Impairment and Dementia of Alzheimer's Type , 2002, NeuroImage.

[55]  J. Price,et al.  Mild cognitive impairment represents early-stage Alzheimer disease. , 2001, Archives of neurology.

[56]  J. Hardy,et al.  Aβ peptide vaccination prevents memory loss in an animal model of Alzheimer's disease , 2000, Nature.

[57]  R. Motter,et al.  Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse , 1999, Nature.

[58]  P Wach,et al.  Imaging of the active B1 field in vivo , 1996, Magnetic resonance in medicine.